These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3372025)

  • 1. Determination of cefpirome (HR 810) in serum and urine.
    Uihlein M; Klesel N; Seeger K
    Infection; 1988; 16(2):135-40. PubMed ID: 3372025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of cefepime and cefpirome in human serum by high-performance liquid chromatography using an ultrafiltration for antibiotics serum extraction.
    Breilh D; Lavallee C; Fratta A; Ducint D; Cony-Makhoul P; Saux MC
    J Chromatogr B Biomed Sci Appl; 1999 Oct; 734(1):121-7. PubMed ID: 10574197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single and multiple dose pharmacokinetics of intravenous cefpirome (HR 810), a novel cephalosporin derivative.
    Malerczyk V; Maass L; Verho M; Hajdú P; Klesel N; Rangoonwala R
    Infection; 1987; 15(3):211-4. PubMed ID: 3610330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microanalytical high-performance liquid chromatographic assay for cefpirome in human milk and urine.
    Kearns GL; Johnson VA; Hendry IR; Wells TG
    J Chromatogr; 1992 Feb; 574(2):356-60. PubMed ID: 1618972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cefpirome (HR 810), a new cephalosporin derivative administered intramuscularly and intravenously to healthy volunteers.
    Maass L; Malerczyk V; Verho M
    Infection; 1987; 15(3):207-10. PubMed ID: 3610329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, tolerance and pharmacokinetics of 2.0 g cefpirome (HR 810) after single and multiple dosing.
    Badian M; Malerczyk V; Collins JD; Dixon GT; Verho M; Eckert HG
    Chemotherapy; 1988; 34(5):367-73. PubMed ID: 3180904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose linearity testing of intravenous cefpirome (HR 810), a novel cephalosporin derivate.
    Maass L; Malerczyk V; Verho M; Hajdú P; Seeger K; Klesel N
    Infection; 1987; 15(3):202-6. PubMed ID: 3610328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of stability-indicating HPLC method for determination of cefpirome sulfate.
    Zalewski P; Skibiński R; Cielecka-Piontek J; Bednarek-Rajewska K
    Acta Pol Pharm; 2014; 71(5):731-6. PubMed ID: 25362801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Meningeal diffusion of cefpirome in adults].
    Chavanet P; Pechinot A; Waldner-Combernoux A; Kazmierczak A; Portier H
    Pathol Biol (Paris); 1989 May; 37(5):442-5. PubMed ID: 2780101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of cefpirome during continuous venovenous hemofiltration: rationale for an 8-hour dosing interval.
    Banyai M; Thalhammer F; El-Menyawi I; Heinz G; Traunmüller F; Siostrzonek P
    Clin Pharmacol Ther; 2000 Apr; 67(4):368-72. PubMed ID: 10801245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of third-generation cephalosporins by high-performance liquid chromatography in connection with pharmacokinetic studies.
    Péhourcq F; Jarry C
    J Chromatogr A; 1998 Jul; 812(1-2):159-78. PubMed ID: 9691317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of cefpirome during the posttraumatic systemic inflammatory response syndrome.
    Jacolot A; Incagnoli P; Edouard AR; Tod M; Petitjean O; Samii K; Mimoz O
    Intensive Care Med; 1999 May; 25(5):486-91. PubMed ID: 10401943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of a new cephalosporin, SCE-2787, in serum and urine by high-performance liquid chromatography.
    Borner K; Borner E; Lode H
    J Chromatogr; 1993 May; 615(1):174-9. PubMed ID: 8340458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability and degradation pattern of cefpirome (HR 810) in aqueous solution.
    Sugioka T; Asano T; Chikaraishi Y; Suzuki E; Sano A; Kuriki T; Shirotsuka M; Saito K
    Chem Pharm Bull (Tokyo); 1990 Jul; 38(7):1998-2002. PubMed ID: 2268903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent bioanalytical methods for quantification of third-generation cephalosporins using HPLC and LC-MS(/MS) and their applications in pharmacokinetic studies.
    Jin HE; Jin SE; Maeng HJ
    Biomed Chromatogr; 2014 Nov; 28(11):1565-87. PubMed ID: 25294385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single- and multiple-dose pharmacokinetics of intravenous cefpirome (HR810) to healthy volunteers.
    Nakayama I; Akieda Y; Yamaji E; Nitta Y; Ohishi M; Katagiri K; Imamura N; Takase K
    J Clin Pharmacol; 1992 Mar; 32(3):256-66. PubMed ID: 1564130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple-dose pharmacokinetics of cefpirome in long-term hemodialysis with high-flux membranes.
    Thalhammer F; Schmaldienst S; Elmenyawi I; Atteneder M; Burgmann H; Hollenstein U; Georgopoulos A; Graninger W; Putz D; Rosenkranz AR; Mayer G; Hörl WH; Breyer S
    Clin Pharmacol Ther; 1996 Dec; 60(6):645-50. PubMed ID: 8988066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an analytical method for cefpirome in plasma by simplified HPLC technique and its applications.
    Sriwiriyajan S; Mahatthanatrakul W
    Arzneimittelforschung; 2010; 60(6):336-9. PubMed ID: 20648924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, tolerance and pharmacokinetics of cefpirome administered intramuscularly to healthy subjects.
    Meyer BH; Muller FO; Luus HG; Drees B; Röthig HJ; Badian M; Eckert HG
    J Antimicrob Chemother; 1992 Apr; 29 Suppl A():63-70. PubMed ID: 1601759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative determination of cefotaxime and desacetyl cefotaxime in serum and bile by bioassay and high-performance liquid chromatography.
    Kees F; Strehl E; Seeger K; Seidel G; Dominiak P; Grobecker H
    Arzneimittelforschung; 1981; 31(2):362-5. PubMed ID: 6261772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.